Oncology & Cancer

Decision regret uncommon after radical prostatectomy, IMRT

(HealthDay)—For patients with prostate cancer treated with radical prostatectomy (RP) and post-prostatectomy image-guided intensity-modulated radiotherapy (IG-IMRT), decision regret (DR) is uncommon and occurs more often ...

Oncology & Cancer

A new method for prostate cancer imaging

Prostate cancer is one of the most common cancers in men. Tumor growth is critically regulated by the androgen receptor, and treatment strategies to lower androgens, such as testosterone, are a mainstay of clinical treatment. ...

Oncology & Cancer

Prostate cancer diagnoses down from 2011 to 2013

(HealthDay)—From 2011 to 2013 there was a decrease in prostate cancer (PC) diagnoses, especially for younger men and low-risk disease, according to a research letter published online June 23 in JAMA Oncology.

Oncology & Cancer

ADT plus radiotherapy ups survival in metastatic prostate CA

(HealthDay)—For men with metastatic prostate cancer (mPCa), overall survival (OS) is improved for those treated with androgen deprivation therapy (ADT) and prostate radiotherapy (RT), compared with ADT alone, according ...

Diabetes

Study explains how low testosterone raises diabetes risk

Doctors have long known that men with low testosterone are at greater risk for developing type 2 diabetes. For the first time, researchers have identified how testosterone helps men regulate blood sugar by triggering key ...

page 17 from 32